BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 38709808)

  • 1. Comparison of interventions for Barrett's esophagus: A network meta-analysis.
    Zhang Q; Li M; Jin X; Zhou R; Ying Y; Wu X; Jing J; Pan W
    PLoS One; 2024; 19(5):e0302204. PubMed ID: 38709808
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment for Barrett's oesophagus.
    Rees JR; Lao-Sirieix P; Wong A; Fitzgerald RC
    Cochrane Database Syst Rev; 2010 Jan; 2010(1):CD004060. PubMed ID: 20091557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term outcomes of patients with Barrett's esophagus and high-grade dysplasia or early cancer treated with endoluminal therapies with intention to complete eradication.
    Guarner-Argente C; Buoncristiano T; Furth EE; Falk GW; Ginsberg GG
    Gastrointest Endosc; 2013 Feb; 77(2):190-9. PubMed ID: 23317687
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endoscopic ablation of dysplastic Barrett's oesophagus comparing argon plasma coagulation and photodynamic therapy: a randomized prospective trial assessing efficacy and cost-effectiveness.
    Ragunath K; Krasner N; Raman VS; Haqqani MT; Phillips CJ; Cheung I
    Scand J Gastroenterol; 2005 Jul; 40(7):750-8. PubMed ID: 16118910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Durability of radiofrequency ablation in Barrett's esophagus with dysplasia.
    Shaheen NJ; Overholt BF; Sampliner RE; Wolfsen HC; Wang KK; Fleischer DE; Sharma VK; Eisen GM; Fennerty MB; Hunter JG; Bronner MP; Goldblum JR; Bennett AE; Mashimo H; Rothstein RI; Gordon SR; Edmundowicz SA; Madanick RD; Peery AF; Muthusamy VR; Chang KJ; Kimmey MB; Spechler SJ; Siddiqui AA; Souza RF; Infantolino A; Dumot JA; Falk GW; Galanko JA; Jobe BA; Hawes RH; Hoffman BJ; Sharma P; Chak A; Lightdale CJ
    Gastroenterology; 2011 Aug; 141(2):460-8. PubMed ID: 21679712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnosis and Management of Low-Grade Dysplasia in Barrett's Esophagus: Expert Review From the Clinical Practice Updates Committee of the American Gastroenterological Association.
    Wani S; Rubenstein JH; Vieth M; Bergman J
    Gastroenterology; 2016 Nov; 151(5):822-835. PubMed ID: 27702561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The diagnosis and management of Barrett's esophagus.
    DeMeester SR; DeMeester TR
    Adv Surg; 1999; 33():29-68. PubMed ID: 10572561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Longitudinal outcomes of radiofrequency ablation versus surveillance endoscopy for Barrett's esophagus with low-grade dysplasia.
    Kahn A; Al-Qaisi M; Kommineni VT; Callaway JK; Boroff ES; Burdick GE; Lam-Himlin DM; Temkit M; Vela MF; Ramirez FC
    Dis Esophagus; 2018 Apr; 31(4):. PubMed ID: 29036431
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The case for endoscopic treatment of non-dysplastic and low-grade dysplastic Barrett's esophagus.
    Fleischer DE; Odze R; Overholt BF; Carroll J; Chang KJ; Das A; Goldblum J; Miller D; Lightdale CJ; Peters J; Rothstein R; Sharma VK; Smith D; Velanovich V; Wolfsen H; Triadafilopoulos G
    Dig Dis Sci; 2010 Jul; 55(7):1918-31. PubMed ID: 20405211
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liquid nitrogen spray cryotherapy-based multimodal endoscopic management of dysplastic Barrett's esophagus and early esophageal neoplasia: retrospective review and long-term follow-up at an academic tertiary care referral center.
    Kaul V; Bittner K; Ullah A; Kothari S
    Dis Esophagus; 2020 Apr; 33(4):. PubMed ID: 31909783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of subsquamous high-grade dysplasia and adenocarcinoma after successful radiofrequency ablation of Barrett's esophagus.
    Titi M; Overhiser A; Ulusarac O; Falk GW; Chak A; Wang K; Sharma P
    Gastroenterology; 2012 Sep; 143(3):564-566.e1. PubMed ID: 22561053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cryotherapy and Radiofrequency Ablation for Eradication of Barrett's Esophagus with Dysplasia or Intramucosal Cancer.
    Thota PN; Arora Z; Dumot JA; Falk G; Benjamin T; Goldblum J; Jang S; Lopez R; Vargo JJ
    Dig Dis Sci; 2018 May; 63(5):1311-1319. PubMed ID: 29524114
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospective randomized trial of argon plasma coagulation ablation versus endoscopic surveillance of Barrett's esophagus in patients treated with antisecretory medication.
    Bright T; Watson DI; Tam W; Game PA; Ackroyd R; Devitt PG; Schoeman MN
    Dig Dis Sci; 2009 Dec; 54(12):2606-11. PubMed ID: 19101798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recurrence of subsquamous dysplasia and carcinoma after successful endoscopic and radiofrequency ablation therapy for dysplastic Barrett's esophagus.
    Lee JK; Cameron RG; Binmoeller KF; Shah JN; Shergill A; Garcia-Kennedy R; Bhat YM
    Endoscopy; 2013 Jul; 45(7):571-4. PubMed ID: 23592390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of Barrett's esophagus with dysplasia refractory to radiofrequency ablation.
    Raphael KL; Trindade AJ
    World J Gastroenterol; 2020 May; 26(17):2030-2039. PubMed ID: 32536772
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Persistent intestinal metaplasia after endoscopic eradication therapy of neoplastic Barrett's esophagus increases the risk of dysplasia recurrence: meta-analysis.
    Sawas T; Alsawas M; Bazerbachi F; Iyer PG; Wang KK; Murad MH; Katzka DA
    Gastrointest Endosc; 2019 May; 89(5):913-925.e6. PubMed ID: 30529044
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes of Radiofrequency Ablation versus Endoscopic Surveillance for Barrett's Esophagus with Low-Grade Dysplasia: A Systematic Review and Meta-Analysis.
    Klair JS; Zafar Y; Nagra N; Murali AR; Jayaraj M; Singh D; Rustagi T; Krishnamoorthi R
    Dig Dis; 2021; 39(6):561-568. PubMed ID: 33503615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular evaluation of ablative therapy of Barrett's oesophagus.
    Hage M; Siersema PD; Vissers KJ; Steyerberg EW; Haringsma J; Kuipers EJ; van Dekken H
    J Pathol; 2005 Jan; 205(1):57-64. PubMed ID: 15586364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endoprevention of esophageal cancer: endoscopic ablation of Barrett's metaplasia and dysplasia.
    Wolfsen HC
    Expert Rev Med Devices; 2005 Nov; 2(6):713-23. PubMed ID: 16293098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictive factors for initial treatment response after circumferential radiofrequency ablation for Barrett's esophagus with early neoplasia: a prospective multicenter study.
    van Vilsteren FG; Alvarez Herrero L; Pouw RE; Schrijnders D; Sondermeijer CM; Bisschops R; Esteban JM; Meining A; Neuhaus H; Parra-Blanco A; Pech O; Ragunath K; Rembacken B; Schenk BE; Visser M; ten Kate FJ; Meijer SL; Reitsma JB; Weusten BL; Schoon EJ; Bergman JJ
    Endoscopy; 2013 Jul; 45(7):516-25. PubMed ID: 23580412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.